(Q40002363)

16 September 2017

title

Therapeutic effects of recombinant human endostatin adenovirus in a mouse model of malignant pleural effusion (English)

1 reference

16 September 2017

1 reference

Fang Fang

1

1 reference

16 September 2017

Ping Chen

2

1 reference

16 September 2017

Xin Wu

3

1 reference

16 September 2017

Li Yang

4

1 reference

16 September 2017

Xun Yang

5

1 reference

16 September 2017

Zhen-Xiang Xi

6

1 reference

16 September 2017

Bin-Wen Zhou

7

1 reference

16 September 2017

Xi-Kun Zhou

8

1 reference

16 September 2017

Zhi-Yong Qian

9

1 reference

16 September 2017

Bo Xiao

10

1 reference

16 September 2017

Yu-Quan Wei

11

1 reference

16 September 2017

publication date

15 February 2009

1 reference

Journal of Cancer Research and Clinical Oncology

16 September 2017

published in

1 reference

16 September 2017

volume

135

1 reference

16 September 2017

issue

9

1 reference

16 September 2017

page(s)

1149-1157

1 reference

Management of malignant pleural effusions

16 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0555-Y

Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0555-Y

Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0555-Y

Phase I study of recombinant human endostatin in patients with advanced solid tumors

21 January 2018

1 reference

12 December 2020

Angiogenesis. A boost for tumor starvation

1 reference

12 December 2020

Intratracheal Gene Delivery with Adenoviral Vector Induces Elevated Systemic IgG and Mucosal IgA Antibodies to Adenovirus andβ-Galactosidase

1 reference

12 December 2020

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses

1 reference

12 December 2020

Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions

1 reference

12 December 2020

Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions

1 reference

12 December 2020

Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis

1 reference

12 December 2020

Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.

1 reference

12 December 2020

Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.

1 reference

12 December 2020

Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites

1 reference

12 December 2020

Angiogenesis and lung cancer: potential for therapy

1 reference

12 December 2020

Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions

1 reference

12 December 2020

In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.

1 reference

12 December 2020

Talc for pleurodesis?

1 reference

12 December 2020

Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size

1 reference

12 December 2020

Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine

1 reference

12 December 2020

Zoledronic acid is effective against experimental malignant pleural effusion.

1 reference

12 December 2020

Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions

1 reference

12 December 2020

Adenovirus-mediated intra-tumoral delivery of the human endostatin gene inhibits tumor growth in nasopharyngeal carcinoma

1 reference

12 December 2020

The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells

1 reference

12 December 2020

Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer

1 reference

12 December 2020

Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.

1 reference

12 December 2020

Tumor necrosis factor-alpha promotes malignant pleural effusion

1 reference

12 December 2020

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

12 December 2020

ZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural effusions in a non-small cell lung cancer model

1 reference

12 December 2020

Neutralized adenovirus-immune complexes can mediate effective gene transfer via an Fc receptor-dependent infection pathway

1 reference

12 December 2020

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

12 December 2020

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

12 December 2020

IL-8 in pleural effusion

1 reference

12 December 2020

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

12 December 2020

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy

1 reference

12 December 2020

Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions

1 reference

12 December 2020

Vascular endothelial growth factor in pleural effusions of different origin

1 reference

12 December 2020

Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease

1 reference

12 December 2020

Long-Term toxicity studies in Canine of E10A, an adenoviral vector for human endostatin gene

1 reference

12 December 2020

Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors

1 reference

12 December 2020

Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts

1 reference

12 December 2020

Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors

1 reference

12 December 2020

Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells

1 reference

12 December 2020

10.1007/S00432-009-0555-Y

Identifiers

DOI

1 reference

16 September 2017

1 reference